Role of endocrine disrupting chemicals in the occurrence of benign uterine leiomyomata: Special emphasis on AhR tissue levels

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5445-5450

  Bidgoli, Sepideh Arbabi ^a   Khorasani, Hoda ^a   Keihan, Heideh ^a   Sadeghipour, Alireza ^b   Mehdizadeh, Abolfazl ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Department of Pathology   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AR; Aryl hydrocarbon receptor (AhR); ER; IHC; Leimyomata; PR; Uterine leiomyoma

Indexed keywords

EID: 84874102434     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5445     Document Type: Article

References (30)

1. Anissa LM Turyk, Henry A, Sally F (2011). Victoria persky uterine leiomyomata in a cohort of great lakes sport fish consumers. Environ Res, 111, 565-72.
2. Azari MR Falaki F, Masoudi Nejad MR (2007). Assessment of dioxin-like compounds released. Tanaffos, 6, 59-64.
3. Balabanic D Rupnik M, Klemencic AK (2011). Negative impact of endocrine-disrupting compounds on human reproductive health. Reprod Fertil Dev, 23, 403-16.
4. Bidgoli SA Ahmadi R, Zavarhei MD (2010). Role of hormonal and environmental factors on early incidence of breast cancer in Iran. Sci Total Environ, 408, 4056-61.
5. Bidgoli SA, Eftekhari T (2011). Role of exogenous and endogenous sources of estrogen on the incidence of breast fibroadenoma: case-control study in Iran. Asian Pac J Cancer Prev, 12, 1289-93.
6. Bidgoli SA Karimi M, Asami Z, Baher H, Djamali ZM (2011). Association between testicular aryl hydrocarbon receptor levels and idiopathic male infertility: a case-control study in Iran. Sci Total Environ, 409, 3267-73.
7. Bidgoli SA Korani M, Bozorgi N, Zavarhei MD, Ziarati P, Akbarzadeh S (2011). Association between glycodelin and aryl hydrocarbon receptor in Iranian breast cancer patients: impact of environmental endocrine disrupting chemicals Asian Pac J Cancer Prev, 12, 2431-5.
8. Brenda E, Marcella W, Steven S, et al (2007). Concentrations and risk of uterine leiomyoma in the seveso. Am J Epidemiol, 166, 79-87.
9. Eduardo FM Szklo, Neil R (2001). Risk factors for uterine leiomyoma: a practice-based case-control study. Am J Epidemiol, 1, 153.
10. Hunter DS, Hodges LC, Eagon PK, et al (2000). Influence of exogenous estrogen receptor ligands on uterine leiomyoma:evidence from an in vitro/in vivo animal model for uterine. Environ Hlth Perspect, 108, 829-34.
11. Kawaguchi K, Fujii S, Konishi I, et al (1991). Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch A Pathol Anat Histopathol, 419, 309-15.
12. Khorram O, Garthwaite M, Golos T (2002). Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions. Mol Hum Reprod, 8, 75-80.
13. Kubínová K, Mára M, Horák P, Kuzel D (2002). Genetic factors in etiology of uterine fibroids. Ceska Gynekol, 77, 58-60.
14. L Amant H, Sadeghi-Bazargani, H Abdollahi, F Ehdaeivand (2011). Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections. Int J General Med, 4, 535-8.
15. Leitao MM, Soslow RA, Nonaka D, et al (2004). Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer, 101, 1455-62.
16. Levy G, Hill MJ, Beall S, et al (2012). Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J Assist Reprod Genet.
17. Marshall LM, Spiegelman D, Goldman MB, et al (1998). A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril, 70, 432-9.
18. S Okolo Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol, 22, 571-88.
19. Samadi AR Lee NC, Flanders WD, Boring JR 3rd, Parris EB (1996). Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Hlth, 86, 858-62.
20. Sepideh AB, Tara E, Reza S (2011). Role of xenoestrogens and endogenous sources of estrogens on the occurrence of premenopausal breast cancer in Iran. Asian Pac J Cancer Prev, 12, 2425-30.
21. Shu Z, Chunhua Q, Stephen H (2003). Safe flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Env Hlth Perspect, 111, 1877-82.
22. Stapleton HM, Baker JE (2003). Arch Environ Contam Toxicol, 45, 227-34.
23. Stapleton HM, Baker JE (2003). Comparing polybrominated diphenyl ether and polychlorinated biphenyl bioaccumulation in a food web in grand travers bay, lake Michigan. Arch Environ Contam Toxicol, 45, 227-34.
24. Sugiura-Ogasawara M, Ozaki Y, Sonta SI, Makino T, Suzumori K (2005). Exposure to bisphenol A is associated with recurrent miscarriage. Hum Reprod, 20, 2325-9.
25. Takeda T, Sakata M, Isobe A, et al (2008). Relationship between metabolic syndrome and uterine leiomyomas: a case-control study. Gynecol Obstet Invest, 66, 14-7.
26. Valdez KE, Shi Z, Ting AY, Petroff BK (2009). Effect of chronic exposure to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats on ovarian gene expression. Reprod Toxicol, 28, 32-7.
27. Van der HE, Bechoux N, Muller M, et al (2009). Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/ synergic activities in human and rat reporter gene assays. Anal Chim Acta, 637, 337-45.
28. Wise LA, Palmer JR, Harlow BL, et al (2004). Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol, 159, 113-23.
29. Wise LA, Radin RG, Palmer JR, et al (2011). Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata. Am J Clin Nutr, 94, 1620-31.
30. Zelieann R Craig, Wei Wang, Jodi A (2011). Flaws endocrinedisrupting chemicals in ovarian function: effects on steroidogenesis. Metabolism And Nuclear Receptor Signaling, 142, 633-46.